In New York, comparator evidence is common in discrimination cases but rarely used in employment contract disputes. Courts ...
Varegacestat, a gamma secretase inhibitor, significantly improved progression-free survival while also meeting all key ...
Where a college professor failed to plead facts making its plausible that his non-selection for tenure was for discriminatory ...
Pharmaceutical Technology on MSN
Takeda to seek approval of plaque psoriasis pill on Phase III trial data
Zasocitinib is also being evaluated in a head-to-head study against Bristol Myers Squibb’s Sotyktu (deucravacitinib) in ...
Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the two pivotal Phase 3 randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib ...
Vor Biopharma has done well to continue to advance its very own global phase 3 study using its dual BAFF/APRIL inhibitor ...
GSK secures FDA approval for its oral gonorrhoea drug as EMA backs expanded RSV vaccine and additional respiratory treatments ...
Pfizer is pursuing pipeline expansions through the Metsera acquisition and a major licensing deal with 3SBio. Find out why ...
London: GSK has announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application for ...
Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback